Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

Biotechnology

Healthcare
$8.91 -1.39%

-$0.26 today

Market cap
$761.36M
Beta
1.60
P/E (TTM)
-9.1
EPS (TTM)
-$1.98
52W Low $4.12High $25.77

Volume 1.11M

Average 1.02M

Price history

Monte Rosa Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-36.99%

Period high

$25.31

Period low

$8.91

Latest

$8.91

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 5, 2026Nov 5, 2026
10-QNov 5, 2026Nov 5, 2026
4Oct 6, 2026Oct 6, 2026
8-KOct 1, 2026Oct 1, 2026
8-KSep 8, 2026Sep 8, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 6, 2026Aug 6, 2026
4Jul 17, 2026Jul 17, 2026
4Jul 16, 2026Jul 16, 2026
SC 13G/AJul 8, 2026Jul 8, 2026
4Jul 7, 2026Jul 7, 2026
SC 13D/AJul 6, 2026Jul 6, 2026
4Jul 6, 2026Jul 6, 2026

Competitors

Who does Monte Rosa Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about GLUE's filings, answered from its disclosures.

What is the latest GLUE filing?

The latest filing shown is 8-K dated Nov 5, 2026.

How many recent filings does GLUE have?

Intrinsic Alpha currently shows 20 recent filings for GLUE.